Bibliometrics Analysis of Studies on Hypertrophic Cardiomyopathy From 2018 to 2022
10.3881/j.issn.1000-503X.15892
- VernacularTitle:2018至2022年肥厚型心肌病研究概况的文献计量学分析
- Author:
Tao LU
1
;
Zhengyang LU
;
Yanhai MENG
;
Changsheng ZHU
;
Zining WU
;
Shuiyun WANG
Author Information
1. 中国医学科学院 北京协和医学院 国家心血管病中心 心血管疾病国家重点实验室阜外医院成人外科中心,北京 100037
- Keywords:
hypertrophic cardiomyopathy;
sudden death;
gene;
mavacamten;
bibliometrics
- From:
Acta Academiae Medicinae Sinicae
2024;46(3):377-383
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the research progress and hot topics in hypertrophic cardiomyopathy from 2018 to 2022.Methods The publications in the field of hypertrophic cardiomyopathy from January 1,2018 to December 31,2022 were retrieved from Web of Science core collection database and included for a bibliomet-ric analysis.Results A total of 6355 publications were included,with an average citation frequency of 7 times.The year 2021 witnessed the most publications(1406).The analysis with VOSviewer showed that the re-search on sudden death related to hypertrophic cardiomyopathy,especially the predictive value of late gadolini-um-enhanced cardiac MRI in sudden death,was a hot topic.In addition,gene detection and the new drug mava-camten became hot research topics.The United States was the country with the largest number of publications and the highest citation frequency in this field.Chinese scholars produced the second largest number of publications,which,however,included few high-quality research results.Conclusions Risk stratification and prevention of sudden death is still an important and hot research content in the field of hypertrophic cardiomyopathy.Chinese scholars should carry out multi-center cooperation in the future to improve the research results.
